A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
University of Chicago
University of Washington
Massachusetts General Hospital
University of Ulm
BeOne Medicines
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Gilead Sciences
Incyte Corporation
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
University of Washington
Acerta Pharma BV
Universität des Saarlandes
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
University of Maryland, Baltimore
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Miami
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Oncternal Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
MEI Pharma, Inc.
AstraZeneca
MEI Pharma, Inc.
BeiGene
BeiGene
Genmab
Stanford University
Academic and Community Cancer Research United
University of Rochester
Columbia University
Altor BioScience
City of Hope Medical Center
University of Colorado, Denver
City of Hope Medical Center
Eastern Cooperative Oncology Group
Stanford University
City of Hope Medical Center
Mayo Clinic
University of Nebraska
University of Nebraska